DKK1 and prostate carcinoma: Due to inherent difficulties associated with the production and purification of a large quantity of DKK1 required for in vivo xenograft experiments, the in vivo prostate cancer xenograft experiment has not been performed, but is warranted in the future to confirm the inhibitory effects on DKK1 on prostate tumor growth and progression.